Bloom Health Partners Inc. (CSE:BLMH)

Bloom Health Partners Inc. (CSE:BLMH), a healthcare company with a registered address in Vancouver, British Columbia, was placed in receivership on January 3, on application by CPL Investments LLC and Uloo Partners LLC (collectively, the "Sellers"). The company wholly owns Bloom Health Holdings Corp. (the "Buyer"), a Delaware corporation. In June 2021, the Buyer purchased the Sellers' interest in Round Hill Health Partners, LLC for consideration of US$12,250,000. The Buyer has repeatedly failed to make payments owed to Sellers. After granting the Buyer two waivers, the Sellers demanded payment in late October 2022. In November 2022, the company informed the Sellers that the company's board and its interim CEO had resigned, and that it intended to wind down its business. As a result, the Sellers sought the appointment of a receiver to act as the company's management and continue operations until July 31, 2023, so that the company can fulfil its contract to supply COVID-19 testing services to the Texas Department of State Health Services, coordinated with an orderly wind down and sale of redundant assets. BDO was appointed Receiver. Farris is counsel for the Sellers. By Dina Milivojevic

Laboratoires Bodycad inc.

Laboratoires Bodycad inc., a Québec City, Québec-based orthopaedic company specialized in the design and manufacturing of revolutionary and personalized products based on the anatomical specifications of a patient using the company’s proprietary Personalized Restoration™ software, obtained CCAA protection on December 22. Raymond Chabot was appointed monitor. Norton Rose Fulbright is counsel for Santé BB inc. (the DIP lender), Fasken is counsel for the company and Stein Monast is counsel for IQ. By Dina Milivojevic

Manitoba Clinic Medical Corporation (“Medco”)

Manitoba Clinic Medical Corporation ("Medco"), which operates the largest private healthcare clinic in Manitoba, and The Manitoba Clinic Holding Co. Ltd., which owns the real property where the clinic operates, obtained an initial order under the CCAA on November 30. Medco plays a significant role in Manitoba’s healthcare system, generating 90% of its revenue by billing the Manitoba Department of Health for services performed by physicians who enter into service agreements with Medco. In 2010, plans were made to construct a state of the art, ten-floor facility and to add two floors to the existing parkade, which was to be done in partnership with the CancerCare Manitoba Foundation. However, the second phase of construction, which was the construction of a new facility for CancerCare, did not proceed, and the companies were left with the large parkade. 52,000 square feet of space in the facility also remains unoccupied. In addition, in the past year, the companies have suffered losses due to, among other things, recent physician departures and an inability to recruit a full complement of physicians, which has negatively affected the companies' ability to generate income through invoicing Manitoba Health and recovering on overhead. A&M was appointed monitor. Counsel is Taylor McCaffrey for the companies, McDougall Gauley for the monitor and MLT Aikins for CIBC. By Dina Milivojevic

Integrated Life Care (McLennan) Inc. and Integrated Life Care Inc.

Integrated Life Care (McLennan) Inc. and Integrated Life Care Inc., which operate the Manoir Du Lac long-term care facility for seniors based in McLennan, Alberta, were placed in receivership on November 29, on application by BMO, owed approximately $16 million. EY was appointed receiver. Counsel is McCarthy Tétrault for BMO, Reynolds Mirth Richards & Farmer for the companies and BLG for the receiver. By Dina Milivojevic

Endoceutics Inc. and certain of its affiliates (collectively, the “Endo Group”)

Endoceutics Inc. and certain of its affiliates (collectively, the "Endo Group"), a Montréal, Québec-based private pharmaceutical business operating in the fields of women’s health and hormone-sensitive cancer prevention and treatment, obtained CCAA protection on September 28. Despite the Endo Group's significant progress over the years, it has encountered financial difficulties requiring the implementation of a restructuring process, with a view to continuing to develop, produce and market products, including its flagship product Intrarosa. EY was appointed Monitor, and PwC has been engaged as financial advisor to CRG Servicing LLC, the senior secured lender. Counsel is McCarthy's for the Endo Group, Stikeman Elliott for the Monitor and Osler for CRG. By Dina Milivojevic

Paladin Labs Canadian Holding Inc. and Paladin Labs Inc.

Paladin Labs Canadian Holding Inc. and Paladin Labs Inc., Canadian debtors which are part of a global specialty pharmaceutical group (collectively, "Endo"), obtained recognition of Endo's Chapter 11 proceedings under Part IV of the CCAA on August 19. Endo’s recent financial performance has deteriorated significantly, largely due to a 55% year-over-year decline in the first half of 2022 from sales of Vasostrict, a branded pharmaceutical that has been one of the company’s leading revenue generators over the last several years. Endo’s highly leveraged capital structure – which consists of funded debt obligations in the aggregate principal amount of approximately US$8.15 billion, which are guaranteed by the Canadian debtors – has become unsustainable as a result of the company’s declining financial performance. The company is also under significant financial pressure due to onerous litigation expenses incurred from defending more than 3,500 lawsuits in a number of jurisdictions, including the US and Canada, largely relating to the marketing and sale of prescription opioids. KSV was appointed as information officer. Canadian counsel is Goodmans for the companies, Bennett Jones for the information officer, Stikeman Elliott for the Ad Hoc First Lien Group, Davies for McKesson Canada Corporation and Osler for Sanis Health Inc., Shoppers Drug Mart Inc. and Loblaw Companies Limited. By Dina Milivojevic

Faissal Mouhamad Professional Corporation (“FMPC”)

Faissal Mouhamad Professional Corporation ("FMPC"), which operates dental clinics in Red Deer and Calgary, Alberta, and 52 Dental Corporation and Delta Dental Corp., which manage the Red Deer and Calgary clinics' business operations, were placed in interim receivership on August 23, on application by RBC, owed approximately $3.1 million. RBC has become increasingly concerned that funds have been diverted from and payments have been made by FMPC to other corporations owned by Faissal Mouhamad, the principal of the companies, contrary to the terms of the credit facilities and the security granted to RBC. FMPC is also in default of the credit facilities and the security in that, among other things, it has failed to repay all amounts owing to RBC on demand, is not conducting day-to-day banking at RBC, has changed the ownership structure of the companies without giving RBC prior written notice and has failed to notify RBC of certain litigation against it. MNP was appointed interim receiver. Counsel is Miller Thomson for RBC and McMillan for the interim receiver.

Medipure Pharmaceuticals Inc. and Medipure Holdings Inc.

Medipure Pharmaceuticals Inc. and Medipure Holdings Inc., Vancouver, British Columbia-based biopharmaceutical companies, had their NOI proceedings continued under the CCAA on August 19. Due to funding issues in the NOI proceedings, the companies had incurred various post-filing arrears, including an estimated $305,000 owed to legal counsel to the company. This resulted in a material adverse change, and it appeared as though the companies may face bankruptcy. However, they were able to locate a new DIP lender, Wealth Management Experts Inc. ("WMEI"), and obtained CCAA protection. WMEI has provided $3.0 million in funds, which are being held in trust. These funds are expected to be sufficient to cover the $792,000 in post-filing arrears owing to employees, creditors and professionals in connection with the NOI proceedings, along with the estimated disbursements to October 28, leaving an estimated $592,000 for professional fees associated with the CCAA proceedings. Deloitte was appointed monitor. Counsel is Boughton Law for the companies and Clark Wilson for the monitor. By Dina Milivojevic

12411300 Canada Inc.

12411300 Canada Inc., which operates two medical clinics located in Mississauga and Brampton, Ontario called Erin Mills Health & Wellness, was placed in receivership on July 22, on application by Triple-I Capital Partners Inc., owed approximately $6.9 million. The company has defaulted on various terms of the Triple-I loan, including by failing to repay the loan on the maturity date, allowing over $50,000 of tax arrears to accrue, and granting a subsequent $2 million charge on the real property from which it operated without Triple-I's prior consent. The company also appears to have abandoned the real property and ceased operations. Crowe Soberman was appointed receiver. Counsel is Scalzi Professional Corporation for Triple-I, Atkinson Law for the company and Miller Thomson for the receiver. By Dina Milivojevic

Medipure Pharmaceuticals Inc.

Medipure Pharmaceuticals Inc. a Vancouver, British Columbia-based biopharmaceutical company conducting research in prescription pharmaceuticals, and its parent company Medipure Holdings Inc., each filed an NOI on May 11. At the time of the filing, the companies' secured and unsecured creditor, SHP Capital, LLC, had an outstanding bankruptcy application against the companies, which was to be heard on May 13. Deloitte is the proposal trustee. Counsel is Boughton Law for the companies and Bennett Jones for SHP Capital. By Dina Milivojevic